Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Open Access
- 1 April 1993
- journal article
- case report
- Published by BMJ in Sexually Transmitted Infections
- Vol. 69 (2) , 112-114
- https://doi.org/10.1136/sti.69.2.112
Abstract
CASE REPORT--SUBJECTS--Three cases are described of long-standing vaginal candidosis due to Candida glabrata. These had failed to respond to local and systemic antifungals. In each case the infecting strain appeared resistant to a range of azole drugs in vitro. CLINICAL COURSE--Case one--This patient recovered following prolonged treatment with oral itraconazole in combination with oral and vaginal nystatin. Case two. Yeasts were eradicated from this patient following cyclical treatment with oral dydrogesterone; prolonged vaginal treatment with nystatin may have helped. Case three. This patient did not respond to a prolonged course of oral itraconazole in combination with vaginal and oral nystatin, oral medroxyprogesterone or intravaginal boric acid. Eradication of C glabrata was finally achieved by local application of 1% gentian violet. Shortly after eradication of the C glabrata infection, both Case two and Case three developed infections with other Candida species responsive to azole antifungals.Keywords
This publication has 5 references indexed in Scilit:
- TORULOPSIS-GLABRATA VAGINITIS - CLINICAL ASPECTS AND SUSCEPTIBILITY TO ANTIFUNGAL AGENTS1990
- FLUCONAZOLE RESISTANCE IN CANDIDA GLABRATAThe Lancet, 1988
- Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrataJournal of Antimicrobial Chemotherapy, 1986
- Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.1986
- Genital Yeast InfectionsBMJ, 1972